Skip to main content
SpringerLink
Log in

BCC and SCC ADRs due to immunosuppressants or hydrochlorothiazide

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dubrall D, et al. Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany Drugs in R and D : 22 Nov 2022. Available from: URL: https://doi.org/10.1007/s40268-022-00407-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

BCC and SCC ADRs due to immunosuppressants or hydrochlorothiazide. Reactions Weekly 1934, 5 (2022). https://doi.org/10.1007/s40278-022-28386-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28386-x

Search

Navigation